R
Richard M. Weinshilboum
Researcher at Mayo Clinic
Publications - 571
Citations - 33641
Richard M. Weinshilboum is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Pharmacogenetics & Thiopurine methyltransferase. The author has an hindex of 86, co-authored 529 publications receiving 31166 citations. Previous affiliations of Richard M. Weinshilboum include University of Rochester & Royal Hallamshire Hospital.
Papers
More filters
Patent
Histamine-N-methyltransferase variants associated with histaminergic disease
TL;DR: In this article, a histamine-N-methyltransferase intron variant sequence associated with a histaminergic disease was found to be associated with Parkinson's disease, and a method for characterizing patients diagnosed with the disease was described.
Journal ArticleDOI
Study of Meditation and Blood Pressure
Patent
Biomarkers for acetaminophen toxicity
TL;DR: In this article, the authors present materials and methods for evaluating cellular responses to acetaminophen and assessing susceptibility to liver damage, and evaluate the effect of the drug on the liver.
Journal ArticleDOI
Genetic polymorphisms and correlation with treatment induced cardiotoxicity and prognosis in breast cancer patients.
Parvin F. Peddi,Peter A. Fasching,Duan Liu,E. Quinaux,Nicholas J. Robert,Vicente Valero,John Crown,Carla I. Falkson,Adam Brufsky,Julie M. Cunningham,Richard M. Weinshilboum,Tadeusz Pienkowski,Wolfgang Eiermann,Miguel Martin,Valerie Bee,Xiaoyang Wang,Liewei Wang,Eric Yang,Dennis J. Slamon,Sara A. Hurvitz +19 more
TL;DR: In the largest study to date to evaluate whether two polymorphisms are associated with DFS and/or cardiac toxicity in HER2 positive breast cancer treated with trastuzumab and/ or anthracyclines, no correlation was observed.